to PDF
Transcription
to PDF
Articulate C CELE orin BRAT ES 30 YEAR Corin newsletter 1985– S 2015 Issue 1 March 2015 Corin Group acquires Australian orthopaedic technology leader Optimized Ortho Corin Group PLC, a leading global manufacturer and supplier of orthopaedic devices, has acquired Optimized Ortho, an Australian orthopaedics technology company that specialises in providing surgeons with unique state-of-the-art technologies for optimising orthopaedic implant component positioning and procedural innovation. The acquisition provides Corin with an IPprotected technology that is the first of its kind within the orthopaedic field. The combination of the Optimized Positioning System (OPS™) technology, alongside the company’s strong hip and knee portfolio and rapidly expanding global distribution network, provide a strong foundation for future growth of the company. Every patient has a unique pelvic motion which influences how a total hip replacement will function in day-to-day activities. The OPS™ technology, for the first time, gives the surgeon the ability to identify, customise and deliver an exact patient-specific component orientation designed to optimise biomechanics and functional joint performance. continued on page 3... Global Marketing Director update Corin continues to invest heavily in its production facilities Are all polyethylenes created equal? Unity Knee™ Interview with Dr Orhun Muratoglu Respecting the soft tissue envelope - Dr Stefan Kreuzer 8 Calendar of events Forthcoming global meeting and exhibitions calendar COMPANY NEWS USA Corin USA continues to expand its presence across the United States and over the last five years we have seen an unprecedented growth from our ever expanding and innovative hip, knee and advanced bearing portfolio. The Unity Knee™ system continues to generate significant interest with Equibalance™ instrumentation to help address MCL isometry and patient satisfaction outcomes. We are also half way through one of our largest ever clinical IDE investigation initiatives with the Trinity™ ceramic-on-ceramic IDE program. Enrolment in this IDE program will be complete in the first half of 2015 and we look forward to making this advanced bearing available for the Trinity™ cup system in the near future. To prepare for the forthcoming release of our OPS™ technology in the USA we held a national OPS™ training program for our distributors and sales representatives to ensure full support for our surgeon communities over the coming months. We look forward to sharing these exciting developments with you at the forthcoming AAOS in Las Vegas. Italy Corin Italy opens its doors! Strengthening and expanding the global reach of the Corin Group we are delighted to announce the opening of the new Corin Italian subsidiary based in the north of Italy, in the province of Udine. The opening of this subsidiary will enable Corin Group to provide the Italian community of surgeons with innovative and ground breaking products. ‘Our unique approach is focused on a responsive model’, Mr Stefano Alfonsi, CEO and Chairman of Corin Group said. ‘We have a lot more to do. But by working with our Italian customers, building powerful synergies, together we can build many more. We are focused on what innovation will come next to provide our global customers with even more quality, responsive support and responsible innovation worldwide. We are confident that the Italian team will contribute significantly towards Corin’s success in 2015 and grow our presence in the Italian market which is close to my heart’, he added. 2 Company update Andy Sutcliffe – Group Marketing Director 2015 is an exciting year for Corin as we reach an important milestone celebrating 30 years in the orthopaedic community. Corin’s success is not least due to its desire to continue to innovate across our extensive hip, knee, extremities and ligament portfolio but in view of the exciting new phase we are about to embark on. Orthopaedic companies have, for many years, focussed on developing implant solutions with little regard for some of the long standing clinical needs associated with joint replacement. We have recognised the need to challenge these issues head on and to find unique solutions to help improve patient outcomes. The acquisition of Optimized Ortho is one such example and provides a world first technology to identify and deliver an optimised implant orientation in total hip replacement based on individual patient specific pelvic movements during functional activities. We have also recognised the importance of challenging patient satisfaction in knee replacement and, working with an eminent group of global knee surgeons, delivered innovative solutions for our Unity Knee™ platform to help achieve functional soft tissue isometry and better outcomes for patients. We continue to invest heavily in these areas and focus our R&D efforts to address ongoing clinical needs and developments that can help improve patient lives. To support these developments we are also investing heavily in our global infrastructure including new facilities in the US, South Africa, Italy and Australia and a multi-million pound state-of-the-art manufacturing facility at our headquarters in Cirencester, UK. This will support our ever expanding global reach (over 40 countries around the world) giving patients and healthcare practitioners greater access to these technologies. With our commitment to ‘Responsible Innovation’ we are proud to support investments that can help meet the need for improved healthcare solutions and throughout this first issue of our newsletter we would like to share some of our developments, success stories and continued investments we are making to deliver best in class products, services and technologies to support our global partners and surgeon community. AAOS 2015 Corin is delighted to be attending the American Academy of Orthopaedic Surgeons in Las Vegas with their largest ever booth space from Wednesday 25 to Friday 27 March. Please come and visit us at our booth (2625) to discuss our diverse and innovative surgical implant solutions and technologies. Along with our hip, knee, ankle and ligament product portfolio Corin will also be showcasing the Optimized Positioning System (OPS™) for the first time. This technology utilises a dynamic and functional pre-operative simulation to provide predictive, patient-specific information, designed to optimise in vivo component positioning and behaviour together with a unique laser guided positioning system. For further information please contact us at events@coringroup.com or telephone +44 (0)1285 649 230. Optimising outcomes Appropriate acetabular cup orientation is an important factor in reducing instability and maximising the performance of the bearing after Total Hip Arthroplasty (THA). However, post-operative analyses of two large THA cohorts in the US have shown that more than half of cups are malorientated1,2. In addition, there is no consensus as to what inclination and anteversion angles should be targeted, and no consensus on which reference plane these angles should be described3. Commonly, four reference planes are quoted: the anterior pelvic plane, the coronal plane when supine, the coronal plane when in the lateral decubitus position and the coronal plane when standing. Frequently these reference planes are used interchangeably, leading to significant errors in planning and measuring cup orientation due to the differences in pelvic tilt in each of these positions4. For example, a significant majority of cups are still implanted with the patient in the lateral decubitus position, with target angles of 40° inclination and 15° anteversion as defined by Lewinnek et al5. However, Lewinnek’s recommended orientation is referenced to the anterior pelvic plane, an anatomical plane which is specific to each individual, potentially offset by more than 30° from the coronal plane and not accurately reproducible during surgery6. Furthermore, the post-operative analysis will likely be performed on an X-ray with the patient supine. Due to the differences in pelvic tilt, the inclination and anteversion angles of the cup when supine will appear different to those seen on the table or in reference to the anterior pelvic plane7,8. Importantly, edge-loading, accelerated wear, impingement and dislocation occur during functional activities when the position of the pelvis is again altered from that seen on standard radiographs or on the operating table6,9,10,11. These functional pelvic rotations are specific to each individual and change the functional anteversion of the acetabular cup by as much as 25°, potentially causing the cup to be functionally malorientated when walking or rising from a chair12,13. Consequently, the target values for cup orientation need to be customised for each patient to account for these individual functional rotations. Trinity OPS™ is an innovative new technology that provides the surgeon with a pre-operative, dynamic analysis of each patient performing a deep flexion and full extension activity. The software calculates the dynamic force at the hip to be replaced and plots the bearing contact patch, using a Hertzian contact algorithm14, as it traces across the articulating surface. The simulation models multiple cup orientations and the alignment which best centralises the load is chosen by the surgeon from the preoperative report. Once the optimal cup orientation has been determined, a unique patientspecific guide is 3D printed and used intra-operatively with a simple laserguided system to quickly and accurately achieve the planned alignment. Acetabular planning should consider the functional range of motion of an individual’s pelvis to reduce the risk of edge-loading and dislocation. In addition, a simple and accurate delivery system is required to achieve a pre-planned target orientation. Functional pelvic rotations are specific to each individual and change the functional anteversion of the acetabular cup by as much as 25°. References 1. Callanan MC et al. CORR, 2011. 2. Barrack RL et al. JBJSurg[Am], 2013. 3. Harrison CL, et al. J Arthroplasty, 2014. 4. Shon WY et al. Skeletal Radiol, 2008. 5. Lewinnek GE et al. JBJS[Am], 1978. 6. Nishihara S et al.CORR, 2003. 7. Au J et al. Hip Int, 2014. 8. Polkowski GG et al. CORR, 2012. 9. Nadzadi ME et al. J Biomech, 2003. 10.Lazennec JY et al. OTSR, 2013. 11.DiGioia AM et al. CORR, 2006. 12.Mellon SJ et al. IMechE pt H, 2013. 13.Lembeck B et al. Acta Orthop, 2005. 14.Mak MM et al. IMechE pt H, 2002. Responsible Innovation 3 Acute ligament reconstruction using LARS™ after knee dislocation work and recreational sports (fig. 1). Dr Pierre Ranger, Hôpital du Sacré-Coeur de Montreal, Canada Knee dislocation, although very rare (accounting for 0.02% to 0.2% of musculoskeletal injuries1), remains a devastating injury with many complications. Because of the numerous structures damaged in knee dislocations, surgery can involve using combinations of autografts, allografts, and more recently synthetic ligaments such as LARS™ (Ligament Augmentation and Reconstruction System). Synthetic ligaments offer an advantage over auto and allografts in that they are readily available and provide immediate post-operative stability due to lack of a healing period. In addition, using LARS™ in multi-ligament reconstructions can eliminate the need to harvest autograft tissue from the contra-lateral leg which can lead to donor site complications including pain and loss of strength2. LARS™ is a third generation synthetic scaffold incorporating a patented design technology which allows improved longevity and tissue in-growth over previous generation synthetics. Acute combined repair and reconstruction of both cruciate ligaments, posterolateral corner (PLC) and collateral ligaments (LCL and MCL) using LARS™ has been the treatment of choice for acute knee dislocations, treated within ten days of trauma, at our institution. We evaluated the outcome and survival of acute cruciate reconstruction (mean time between trauma and surgery 11 ±8.4 days) using LARS™ ligaments after knee dislocation in 107 patients with a minimum follow-up of 24 months post-surgery. All patients underwent reconstruction of at least both ACL and PCL +/- reconstruction of PLC and/or collateral ligaments. Clinical examination at final follow-up showed the majority of the patients had good stability, with some residual posterior drawer (5-6mm) obtained by Telos examination. Subjective evaluation results showed significant improvement in symptoms and that many patients returned to preinjury levels of 4 Questionnaires Mean (SD) Lysholm (n = 99) 75.4 (±17.6) Tegner (n = 95) 4.6 (±2.0) Meyers (n = 94) 3.1 (±0.8) IKDC (n = 101) 63.6 (±18.9) Figure 1. Subjective outcome scores. Further evaluation of 54 patients at mean 9.2 (±3.5) years follow-up showed no significant change in subjective and objective tests indicating a persistence of knee stability over time. In conclusion we feel that LARS™ provides an effective alternative in the treatment of knee dislocations with excellent short to mid-term clinical outcomes. References: 1. Engebretsen L et al. Knee Surg Sport Traum Arth. 2009. 2. Ardern C et al. J Arthro Rel Surg. 2010. Conservation and technology in modern day THR – Hip cadaveric workshop Mulheim 21-22 April 2015 Following the success of our hip cadaveric workshops through 2014, we are proud to announce the latest meeting for 2015. This year we are extending the outstanding programme to address some of the latest developments in hip replacement today, and additions to Corin’s technology portfolio. This meeting will provide an open and interactive platform to discuss and interrogate conservative hip replacement and optimised implant orientation. There will be a hands-on cadaveric training session with state-of-the-art facilities, with Corin’s hip portfolio (including MiniHip™ and TriFit TS™), and our latest technology offering, Optimised Positioning System (OPS™) available for hands on training. We are looking forward to this meeting building on the success of previous years, and in welcoming delegates and faculty from around the world to join us in sharing best practice in total hip replacement surgery today. For further information please go to www.corinacademy.com. Are all polyethylenes created equal? Interview with Dr Orhun Muratoglu For many years surgeons have been debating the balance between hip bearing stability and polyethylene wear. Advancements in polyethylene have been made over the years, from ultra high molecular weight polyethylene (UHMWPE) to highly crosslinked polyethylene (HXLPE), and more recently vitamin E polyethylenes. Corin has had the unique opportunity to collaborate closely with Massachusetts General Hospital (MGH) in the development and commercialisation of a next-generation vitamin E polyethylene. ECiMa™ is the most advanced polyethylene of its kind, and is only available with Corin’s Trinity™ advanced bearing acetabular system. This interview talks to Dr Orhun Muratoglu about the latest advancements in this technology. ECiMa™ is the most advanced polyethylene of its kind What has driven you and your institution to re-visit HXLPE and further improve on existing technology? We are pleased with the success of the first generation, irradiated and remelted HXLPE. It helped to alleviate a major problem with conventional PE components – that is, osteolysis due mostly to particulate debris generated by excessive wear necessitating revision surgery. For our laboratory the natural next step was to further improve on the existing technology so as to obtain higher strength and fatigue resistance along with low wear and low oxidation. What advantages do you think ECiMa™ offers over other modern day polyethylenes? What are the methods of producing HXLPE and the down-sides? Cross-linking is achieved by radiation, which also results in residual free radicals. These free radicals are responsible for oxidation and embrittlement of polyethylene components both on the shelf and in the patients. First generation highly cross-linked polyethylenes were either remelted or annealed below the melt temperature to improve oxidative stability. Remelting was successful in quenching all of the detectable free radicals. On the other hand, annealing only reduced the concentration of the free radicals and as a result irradiated and annealed polyethylene components showed high levels of oxidation in vivo in less than five years. Irradiated and remelted polyethylene components are showing no detectable oxidation up to ten years of in vivo service; beyond ten years there appears to be some early signs of potential oxidation. While remelting was thought to mostly eliminate the oxidation caused by the residual free radicals, this late onset oxidation is puzzling. We hypothesise that cyclic loading and/or absorbed lipids initiate and progress oxidation in these components. What is special about the processing of ECiMa™ that means free radicals are eliminated but the mechanical properties are maintained? ECiMa™ material is irradiated for crosslinking and reduction in wear, followed by mechanical deformation to anneal or quench the free radicals responsible for oxidation. In addition ECiMa™ contains an antioxidant, vitamin E, to protect the polymer against any oxidative attack in vivo. ECIMa™ is not remelted after irradiation, therefore retains its mechanical properties. What is so important about vitamin E and mechanical annealing? The contained vitamin E actively protects the component from oxidation. This active protection is unlike the first generation technology, which relied on initially reducing/eliminating the free radical burden to impart oxidative stability. The joint fluid contains potential oxidisers, such as lipids, that can be absorbed over time during in vivo use, challenging the oxidative stability of the component. The contained vitamin E will continuously combat these oxidisers and keep the component oxidatively stable. Mechanical annealing helps to reduce residual free radicals in the irradiated material without remelting it, making it oxidatively stable while retaining mechanical properties. How can the surgeon be sure that the body can tolerate extra vitamin E in the body? We have done multiple in vitro tests assessing the possible release of vitamin E from a component under various adverse conditions – at elevated temperatures and in aqueous environments – and under simulated gait. The calculated worst-case values of vitamin E elution in these tests appear to be very low – substantially less than natural plasma vitamin E levels in most adults. Plus, at a nominal concentration of 0.1 wt.% of vitamin E, a relatively large, 50g component would only contain 50mg of vitamin E. Vitamin E toxicity has been associated with large doses (>400 IU/day) over a prolonged period of time; even if all 50mg of vitamin E from the component were somehow lost in a single day, it would still equate to less than 400 IU. In addition the animal studies that we carried out have shown that any vitamin E that might elute out of the components will not adversely affect bone ingrowth and will not cause any adverse tissue reaction. There are many modern day polyethylenes using different methods to try and overcome the issues. Some use no antioxidant, like X3, others use an antioxidant, typically vitamin E. Vitamin E can be blended at the start of the process or doped at the end of the process. X3 is sequentially irradiated and annealed, as a result it contains residual free radicals, explanted X3 acetabular liners and tibial inserts are showing in vivo oxidation. The observations from explanted components would indicate that X3 is not resistant to oxidation in vivo. In contrast, vitamin E stabilised irradiated UHMWPE has shown resistance toward oxidation in laboratory experiments under aggressive aging environments. We have analysed a small number of vitamin E stabilised bearings retrieved at revision surgery (the reason for revision was not related to the polyethylene bearing) and they showed no detectable oxidation up to two years in vivo. ECiMa™ is a blended vitamin E which offers the advantages of uniform distribution of the vitamin E throughout the polyethylene and minimises the elution effect ECiMa™ has shown improved strength and fatigue resistance whilst reducing wear and oxidation in comparison to other modern day polyethylenes. Will vitamin E simply elute out of the device over time and then leave the liner susceptible to future oxidation? We have very strong laboratory data that indicates that vitamin E elution will be minimal. During irradiation, some of the vitamin E becomes chemically linked or grafted to the polyethylene molecules. The grafted vitamin E still protects the polyethylene against oxidation based on our laboratory studies. Responsible Innovation 5 COMPANY NEWS Respecting the soft tissue envelope: Is it a factor in improving patient satisfaction? Stefan Kreuzer, MD PhD Australia Corin Australia continues to develop rapidly with the Sydney offices now expanding to include the global OPS™ production headquarters. The significant uptake of this new technology in combination with the Corin implant range has seen approximately 1000 hips ‘optimized’ over the last 18 months. In combination with the emerging interest in a variety of applications for the LARS™ ligament (including gluteal tendon repair, MCL, PCL, PLC, augmented ACL, and ACJ reconstruction) and the launch of the Zenith™ ankle replacement following reimbursement being granted on 18 March – 2015 will be another exciting year for the Australian business. Forthcoming events supported by an International faculty: LARS™ Cadaver Lab Roadshow 20, 21 & 23 May - Brisbane, Sydney & Melbourne MIAA Masterclass 1-5 June – Adelaide, Melbourne & Sydney United Kingdom Corin UK is proud to be the first team outside of Australia to utilise Optimized Orthopaedics providing this new and innovative service for a challenging case at the Nuffield Orthopaedic Centre in Oxford in February this year. Further cases have already been booked at a number of other centres in the UK as interest in this technology grows. Corin, within the UK market, has long been regarded as a provider of hip systems but the introduction of the Unity Knee™ has helped surgeons in a number of key centres to focus on soft tissue balancing and a better outcome for the patient. With the patients’ outcome as the primary motivation, OPS™ and Unity Knee™ are poised to give the UK market a step change in technology and promises to deliver another successful year for Corin business. 6 Whilst total knee arthroplasty demonstrates excellent longterm survivorship, patient satisfaction is still a prevalent issue with over 20% of patients exhibiting patient dissatisfaction post TKR. In particular anterior knee pain and instability post surgery are some of the most common causes for patient dissatisfaction. Bourne et al demonstrated that over 18-28% of patients experience pain post total knee surgery. In addition mediolateral or varusvalgus instability is the most common cause of instability and leading cause of early clinical failure post total knee arthroplasty (Fehring and Valadie 1994, Fehring 2001, Sharkey 2002). Recent studies (Delport and Bellemans 2014) have demonstrated that collateral ligament strains alter post TKR which may lead to laxity and/or tightness of the ligaments and subsequent instability and loss of motion. In order to prevent patient discomfort, pain, stiffness and/or instability post TKR it may be beneficial to consider the soft tissue envelope, ensuring ligamentous strains after TKR are similar or close to the native situation. Several factors contribute to the state of the soft tissue envelope post total knee arthroplasty; some of these factors are surgeon dependent such as nature and extent of ligamentous releases performed, whilst others are attributable to the implant and instrument system employed during surgery. Our objective with the Unity Knee™ system was to build on over 20 years of extensive knee research, collaborate with a multi-disciplinary team at Corin and a knee specialist surgeon team from USA, Germany, Austria and UK, to design a modern knee system, based on scientific findings, which not only optimises implant geometry but also incorporates advanced instrument concepts to help facilitate soft tissue balance during total knee replacement. We focussed on three fundamental areas for innovation when developing the Unity Knee™ system: 1. Optimising MCL isometry 2. Balancing the extensor mechanism 3. Balancing the soft tisse envelope In this article we review the concept of MCL isometry and its relevance to total knee replacement: 1. Optimising MCL isometry Modern single radius TKR implants have demonstrated the ability to improve mid-flexion stability and reduce anterior knee pain, attributable to improvements in collateral isometry and prevention of paradoxical anterior movement of the femur during flexion (Banks 2007, Mahoney 2002, Blom 2014). However, there have also been studies which do not demonstrate an improvement in function of these designs over traditional knee systems (Hall et al). Fig. 1 The flexion joint-line orientation is altered during TKA. We believe that it is not just the implant geometry which influences isometry of the MCL. Joint-line restoration is crucial to ensure MCL isometry is as near as possible to the physiological condition. However, the native joint-line orientation (varus) is invariably altered during knee surgery as we resect unequal medial and lateral condylar bone to replace them with equal thickness medial and lateral implant condylar shapes. Therefore, it is difficult to ensure both medial and lateral joint-line is maintained through the range of motion post total knee arthroplasty. We believe that since the MCL is the most important stabiliser post TKR, maintaining the medial joint-line should be prioritised during total knee arthroplasty. However, traditional knee surgery instruments incorporate external rotation guides which pivot around a single central axis when dialling in external rotation, resulting in elevation of the medial joint-line. We believe that this shift in the posterior medial joint-line can lead to midflexion laxity and deep-flexion tightening of the MCL. With this in mind, the Unity Knee™ not only optimises the implant geometry In conclusion, whilst there are several factors which can impact patient satisfaction, joint-line preservation and soft tissue balance certainly play a role in improved patient function and knee joint stability post surgery. Since these factors can be impacted by the type of implant and instrumentation employed by the surgeon, we urge caution to surgeons when choosing a TKR system to ensure that both the implant and the instrument platform are given considerable thought and to confirm that each of them assist the surgeon in preserving the femoral joint-line throughout range of motion and minimise strains on the soft tissue envelope in order to optimise stability post TKR. Transepicondylar axis Natural joint line Raised joint line using conventional instruments Conventional resection True medial joint line using EquiBalance™ instruments EquiBalance™ resection Fig. 2. Conventional external rotation guides (left) pivot about a central axis elevating the medial jointline when rotated. In contrast, Unity EquiBalance instruments accommodate preservation of the posterior medial jointline by incorporating a medial axis of rotation (right). to achieve MCL isometry post TKR but also incorporates an advanced innovative femoral alignment system which allows maintenance of both the distal and posterior medial joint-line throughout range of motion thereby consistently restoring the patient’s natural posterior condylar offset so as to optimise post-operative function. COMPANY NEWS Corin is proud to announce the launch of the “myminihip. com” website. Surgeons who perform THA utilising this unique total hip solution can either talk through this information with their patients or direct them to this valuable resource to find out more about their upcoming MiniHip™ procedure. The site includes; ■■ A patient guide on the MiniHip™ system which can be downloaded directly from the site to read later. ■■ A useful ‘find a doctor’ area where patients who get to the site independently can search for surgeons in the USA who carry out the MiniHip™ procedure. We will be expanding this to include other geographies in due course. ■■ Patient stories featuring individual patients experience with their MiniHip™ and here they discuss the effect the surgery has had on their lives. We would be pleased to hear from you with suitable patients and their stories. ■■ Further information available on the site includes sections on understanding arthritis, common conditions affecting the hip, what to expect from surgery and useful links to other relevant websites. We would encourage you to visit myminihip.com and give us your feedback, as we continue to develop the site over the coming months. Conformity | Versatility | Stability TriFit TS™ is the latest addition to the Corin primary hip continuum of care, with the first implantation in September 2012 and over 3000 implantations to date. TriFit TS™ was developed with a world leading developer group and is one of the most advanced cementless tapered stems on the market today. Combined with the Trinity™ cup we are able to offer a world leading hip replacement system incorporating advanced bearing technologies and one of the most advanced stem/cup combinations on the market. Please visit: www.coringroup.com/trifitts Responsible Innovation 7 Zenith™ – overcoming issues in Total Ankle Replacement Ian Winson Fusion has long been considered the treatment gold standard for ankle arthritis. However, loss of joint motion and resultant abnormal gait patterns can lead to significant functional restrictions on patients’ activities and overloading of adjacent, often already arthritic joints. Whilst historical results with Total Ankle Replacement (TAR) have demonstrated poor survivorship, more recent developments in implant design and instrumentation mean that arthroplasty can now be seen as a viable alternative to fusion. Third generation TAR Zenith™, introduced in 2007, was designed specifically to overcome the early issues surrounding ankle replacement. State-of-the-art instrumentation allows reproducible, parallel tibia and talus resection referenced from the joint-line. An innovative talus design, incorporating two anterior pegs and chamfer resection with an open wedge effect, provides primary and rotational stability. Innovative fixation technology incorporating Biomimetic Cementless Coating Technology allows optimal short and long-term osseointegration. The proven TiN bearing surface coating reduces wear by up to 98%. Since 2007, we have implanted more than 100 Zenith™ ankles in Bristol with greater than 96% survivorship at up to five years. Corin’s support and strong focus on surgeon education – through cadaveric teaching courses and Centre of Excellence surgeon visits – has allowed us to advocate the use of Zenith™ through comprehensive surgical skills labs to ensure responsible implantations worldwide. Calendar of events 2015 Venue Dates DAF Kongress University of Bayreuth, Germany 20 - 21 Mar AAOS Annual Meeting Sands EXPO, Las Vegas, NV, USA 25 - 27 Mar Optimizing orthopaedics - Advancing technology, defining solutions: Meet the experts sessions Corin booth 2625, Hall B, Sands EXPO, Las Vegas, NV, USA 25 - 27 Mar Optimizing orthopaedics - Advancing technology, defining solutions: Welcome reception Vinoly Grand Ballroom, Vdara Hotel, Las Vegas, NV, USA 25 Mar Cadaver LAB Shoulder Lyon, France 3 Apr London Hip Meeting QEII Conference Centre, London, UK 9 Apr 23rd Biennial Congress of the SAAS Wild Coast Sun, Kwazulu Natal, South Africa 15 - 18 Apr ICJR World Arthroplasty Congress Palais des Congrès, Paris, France 16 - 18 Apr Shoulder Congress Berlin, Germany 21 - 22 Apr Conservation and Technology in Modern Day THR MEDucation Centre, Mulheim, Germany 21 - 22 Apr Jahrestagung der Vereinigung Süddeutscher Orthopäden und Unfallchirurgen e.V. Kongresshaus, Baden-Baden, Germany 30 Apr - 2 May Zenith Total Ankle Replacement LAB Vesalius Clinical Training Centre, Bristol, UK 8 May LARS Cadaveric LAB Roadshow Brisbane, Sydney and Melbourne, Australia Current Concepts and Controversies Knee Meeting Sixways Stadium, Worcester, UK 20, 21 & 23 May 20 - 21 May 88th Annual Meeting of the JOA Kobe International Conference Center, Japan 21 - 24 May MIAA Masterclass Adelaide, Melbourne and Sydney, Australia 1 - 5 June Cadaver LAB Shoulder Nice, France 5 Jun 11th Symposium on Joint Preserving and Minimally Invasive Surgery of the Hip Fairmont Chateau Laurier, Ottawa, Canada 4 - 6 Jun 10th Biennial ISAKOS Congress Lyon Convention Centre, Lyon, France 7 - 11 Jun The Great Debate Mermaid Conference & Events Centre, London, UK 18 - 19 Jun Welsh Orthopaedic Society - Pan Celtic Meeting Vale of Glamorgan Hotel, Nr Cardiff, UK 18 - 19 Jun Annual Meeting Swiss Orthopaedics Basel, Switzerland 24 - 26 Jun DVSE-Congress Mannheim, Germany 25 - 27 Jun The 128th Annual Meeting of the AOA The Westin Providence, Providence, RI, USA 24 - 27 Jun Important: Not all products are available or cleared for distribution in all international markets. For more details, please contact your local subsidiary or distributor by visiting the Corin worldwide section. www.coringroup.com www.linkedin.com/company/corin-uk-ltd info@coringroup.com www.youtube.com/user/coringroup/ +44 (0) 1285 658 960 http://bit.ly/Zvic7H INTERACTIVE UPDATES Having a say “Do you feel that your work positively impacts people’s lives?” This, and many more questions recently formed a broad-ranging survey aimed at Corin’s workforce worldwide, encouraging everyone to share their opinions of what they think and value. Opinions were sought across a broad spectrum from work environment, management and communication to motivation, reward and recognition. The results will be shared with all employees and will help gain a better understanding of morale, satisfaction, and engagement. It will also help Corin to bring about meaningful improvement to all areas of the business by focusing on positive changes that really matter to staff. New ECiMa™ key features animation www.youtube.com/ user/coringroup/ ECiMa™ vitamin E highly cross-linked polyethylene (HXLPE) represents a new generation in orthopaedic bearing technology. Surgeon Resource Hub Download our iPad app from the iTunes App Store searching Surgeon Resource Hub. http://bit.ly/Zvic7H
Similar documents
to PDF
Andy Sutcliffe, Group Marketing Director at Corin commented, “OPSTM is a first of a kind procedural innovation within the orthopaedic field and it’s great to get global recognition for this achieve...
More informationto PDF
the first FDA-cleared technology to help surgeons achieve functional, patient specific component alignment in total hip replacement. The approval allows Corin to be the first company to offer a tec...
More information